Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration
- PMID: 38399327
- PMCID: PMC10892810
- DOI: 10.3390/pharmaceutics16020273
Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration
Abstract
Recently, nanotechnologies have become increasingly prominent in the field of bone tissue engineering (BTE), offering substantial potential to advance the field forward. These advancements manifest in two primary ways: the localized application of nanoengineered materials to enhance bone regeneration and their use as nanovehicles for delivering bioactive compounds. Despite significant progress in the development of bone substitutes over the past few decades, it is worth noting that the quest to identify the optimal biomaterial for bone regeneration remains a subject of intense debate. Ever since its initial discovery, poly(lactic-co-glycolic acid) (PLGA) has found widespread use in BTE due to its favorable biocompatibility and customizable biodegradability. This review provides an overview of contemporary advancements in the development of bone regeneration materials using PLGA polymers. The review covers some of the properties of PLGA, with a special focus on modifications of these properties towards bone regeneration. Furthermore, we delve into the techniques for synthesizing PLGA nanoparticles (NPs), the diverse forms in which these NPs can be fabricated, and the bioactive molecules that exhibit therapeutic potential for promoting bone regeneration. Additionally, we addressed some of the current concerns regarding the safety of PLGA NPs and PLGA-based products available on the market. Finally, we briefly discussed some of the current challenges and proposed some strategies to functionally enhance the fabrication of PLGA NPs towards BTE. We envisage that the utilization of PLGA NP holds significant potential as a potent tool in advancing therapies for intractable bone diseases.
Keywords: PLGA; bioactive molecules; biocompatibility; biodegradability; biomaterial; bone regeneration; drug delivery; nanoparticles.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







Similar articles
-
Recent advances in PLGA-based biomaterials for bone tissue regeneration.Acta Biomater. 2021 Jun;127:56-79. doi: 10.1016/j.actbio.2021.03.067. Epub 2021 Apr 6. Acta Biomater. 2021. PMID: 33831569 Review.
-
Nanoparticles in Bone Regeneration: A Narrative Review of Current Advances and Future Directions in Tissue Engineering.J Funct Biomater. 2024 Aug 23;15(9):241. doi: 10.3390/jfb15090241. J Funct Biomater. 2024. PMID: 39330217 Free PMC article. Review.
-
Supercritical CO2 foamed composite scaffolds incorporating bioactive lipids promote vascularized bone regeneration via Hif-1α upregulation and enhanced type H vessel formation.Acta Biomater. 2019 Aug;94:253-267. doi: 10.1016/j.actbio.2019.05.066. Epub 2019 May 31. Acta Biomater. 2019. PMID: 31154054
-
Advanced PLGA hybrid scaffold with a bioactive PDRN/BMP2 nanocomplex for angiogenesis and bone regeneration using human fetal MSCs.Sci Adv. 2021 Dec 10;7(50):eabj1083. doi: 10.1126/sciadv.abj1083. Epub 2021 Dec 8. Sci Adv. 2021. PMID: 34878837 Free PMC article.
-
Recent Progress in the Development of Poly(lactic-co-glycolic acid)-Based Nanostructures for Cancer Imaging and Therapy.Pharmaceutics. 2019 Jun 14;11(6):280. doi: 10.3390/pharmaceutics11060280. Pharmaceutics. 2019. PMID: 31197096 Free PMC article. Review.
Cited by
-
Advantages of nanoencapsulation in the delivery of therapeutics for bone regeneration.Nanomedicine (Lond). 2025 Apr;20(8):773-775. doi: 10.1080/17435889.2025.2462518. Epub 2025 Feb 5. Nanomedicine (Lond). 2025. PMID: 39907195 No abstract available.
-
Phytonanoparticles as novel drug carriers for enhanced osteogenesis and osseointegration.Discov Nano. 2025 Jan 16;20(1):11. doi: 10.1186/s11671-024-04164-9. Discov Nano. 2025. PMID: 39821381 Free PMC article. Review.
-
Polymers for the treatment of Alzheimer's disease.Front Pharmacol. 2025 Jan 29;16:1512941. doi: 10.3389/fphar.2025.1512941. eCollection 2025. Front Pharmacol. 2025. PMID: 39944627 Free PMC article. Review.
-
Application of gelatin-based composites in bone tissue engineering.Heliyon. 2024 Aug 14;10(16):e36258. doi: 10.1016/j.heliyon.2024.e36258. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39224337 Free PMC article. Review.
-
Exploring the Potential of PLGA Nanoparticles for Enhancing Pulmonary Drug Delivery.Mol Pharm. 2025 Jul 7;22(7):3542-3562. doi: 10.1021/acs.molpharmaceut.5c00118. Epub 2025 Jun 6. Mol Pharm. 2025. PMID: 40479726 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous